ArticleCancers2019

Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy (The PRONE Study).

Chantal M Driessen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.